pioneer 6 oral semaglutide cardiovascular outcomes trial results (CVOT) My first paper in NEJM

Name: pioneer 6 oral semaglutide cardiovascular outcomes trial results (CVOT) My first paper in NEJM
Brand: matisco.be
SKU: 73734746036
Price: 24.52 USD
Availability: InStock
Rating: 4.1764 (23 reviews)

SKU: 73734746036

4.2

USD24.52 USD72.52

Pay in 4 interest-free payments of $6.13 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

My first paper in NEJM ! Two weeks ago the results from PIONEER 6, a cardiovascular outcomes trial examining the safety of oral semaglutide versus placebo, were published in the prestigious New Cardiovascular Outcomes, Safety, and Tolerability With Oral Semaglutide: Insights for Managed Care AJMC Frontiers Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6 Cardiovascular benefits of semaglutide: a systematic review and meta analysis of randomized controlled trials PMC

Store: matisco.be · Domain: matisco.be

Description

Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole